瑞舒伐他汀治疗冠心病急性心肌梗死的效果（内科学资料）.docVIP

瑞舒伐他汀治疗冠心病急性心肌梗死的效果（内科学资料） 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：瑞舒伐他汀治疗冠心病急性心肌梗死的效果 1 1 资料与方法 3 2 结果 6 3 讨论 7 文2：急性心肌梗死患者进行内科护理的效果 8 1资料与方法 8 2结果 11 3讨论 11 参考文摘引言： 11 原创性声明（模板） 13 文章致谢（模板） 14 正文 瑞舒伐他汀治疗冠心病急性心肌梗死的效果（内科学资料） 文1：瑞舒伐他汀治疗冠心病急性心肌梗死的效果 [Abstract] Objective To investigate the clinical effect of Rosuvastatin in the treatment of patients with acute myocardial infarction of coronary heart disease. Methods Ninety six cases of patients with acute myocardial infarction of coronary heart disease admitted to Hebei Friendship Hospital from December 2013 to June 2015 were randomly divided into observation group and control group， with 48 cases in each group. The control group was treated with routine treatment， and the observation group was treated with Rosuvastatin on basis of the conventional therapy. The levels of left ventricular ejection fraction （LVEF）， flow-mediated dilation （FMD）， C-reactive protein （CRP）， total cholesterol （TC）， triacylglycerol （TG）， low deity lipoprotein cholesterin （LDL-C）， high deity lipoprotein cholesterol （HDL-C） and hemorheology of the two groups before and after treatment were compared. Results The levels of LVEF， FMD， CRP of the two groups after treatment were significantly improved compared with those before treatment （P ）， and the levels of FMD， LVEF of the observation group after treatment were higher than those of control group， the level of CRP was lower than that of control group， the differences were statistically significant （P ）； the levels of blood lipid of the two groups after treatment were significantly improved compared with those before treatment （P ）， and the levels of TC， TG， LDL-C of the observation group after treatment were lower than those of control group， the level of HDL-C was higher than that of control group， the differences were statistically significant （P ）； the hemorheology indexes of the two groups after treatment were significantly improved compared with those be